Subscribe and Listen to the Mirelle Method® Podcast

This Episode: Modern Science for Menopausal Body Regeneration

 

There is a sentence I hear from women far too often: “I was told this is just menopause.”

Sometimes they are talking about hot flashes. More often, they are describing something much larger.

They are not sleeping the way they used to.

Their energy has changed.

Their body composition is changing despite their best efforts.

They may feel more anxious, more irritable, or simply less like themselves.

Their concentration is different.

Sex may have become uncomfortable or painful.

Their libido may have diminished.

Their vaginal tissues may feel dry or irritated.

Some women notice that sexual sensation has changed, or that orgasm takes longer, feels different, or has become difficult to achieve.

Others are suddenly leaking urine when they laugh, cough, exercise, or sneeze.

And sometimes a woman sits in front of me and says something very simple:

“I just don’t feel like myself anymore.”

I take that seriously. Menopause is not simply the end of menstrual periods. It is a significant physiologic transition involving multiple interconnected systems.

• Estrogen changes profoundly.
• Progesterone changes.
• Androgen physiology changes.
• The vaginal and urinary tissues change.
• Sleep, thermoregulation, metabolism, bone, body composition, mood, pelvic floor function, sexual function, and quality of life may all be affected.

This is why I think about menopausal hormones in a particular way.

Hormones do not function as soloists. They function as an orchestra.

When one section of an orchestra changes, the sound of the entire symphony can change.

Female physiology is much the same.

My goal is not simply to identify one low hormone and replace it.

My goal is to understand what changed, how those changes are affecting the woman as a whole, and which parts of her physiology actually need attention.

That is where personalized menopause medicine begins.

Listening to the Whole Woman

When a woman comes to see me for menopause care, I want to understand much more than her laboratory results.

• I want to know how she is sleeping.
• How she feels when she wakes up.
• Whether her energy has changed.
• Whether her body composition has changed.
• Whether she still feels mentally sharp.
• Whether intimacy has become uncomfortable.
• Whether sexual desire or sensation has changed.
• Whether orgasm has changed.
• Whether she is experiencing vaginal dryness.
• Whether she has developed urinary urgency or leakage.
• Whether she feels strong through her pelvic floor.
• Whether her mood feels different.
• Whether she still feels comfortable in her own body.
• Laboratory testing can be extremely useful, but it is only one part of the clinical picture.
• Symptoms matter.
• Medical history matters.
• Metabolic health matters.
• Sexual health matters.
• Pelvic floor health matters.
• The woman’s goals matter.
• And her response to treatment matters.

That is the foundation of personalized menopause care.

The Hormonal Orchestra

Estrogen is one of the most important hormones in female physiology, but estrogen does not act alone.

Estrogens interact with progesterone, testosterone, DHEA, and other steroid hormone pathways.

These systems also intersect with thyroid physiology, insulin sensitivity, stress physiology, sleep, nutrition, vascular health, medications, body composition, and individual receptor responsiveness.

This helps explain why two women with similar laboratory results can feel completely different.

It also explains why two women describing similar symptoms may ultimately need different treatment plans.

For me, hormone optimization is not about forcing every woman toward the same laboratory target.

It is about asking:

What does this particular woman need?

Laboratory testing provides information.

Symptoms provide information.

Her medical history provides information.

Her metabolic health provides information.

Her sexual function provides information.

The way she responds to therapy provides information.

Precision comes from putting all of those pieces together.

Why I Use Personalized Compounded BHRT

The concept of the hormonal orchestra is one of the reasons I value personalized compounded bioidentical hormone replacement therapy.

Manufactured hormone medications are necessarily produced in specific strengths, formulations, and delivery systems.

Those options can work very well for many women.

But women themselves are not standardized.

A woman entering menopause at 49 with severe hot flashes, insomnia, declining sexual desire, and an intact uterus is not the same as a 58 year old woman whose primary concerns are vaginal dryness, painful intercourse, changing body composition, reduced sexual sensation, and urinary symptoms.

Their histories are different.

Their symptoms are different.

Their physiology is different.

Their priorities may be different.

Their response to treatment may be different.

For some women, the ability to customize a hormone prescription is extremely valuable.

Federal compounding law recognizes patient specific prescribing and circumstances in which a change made for an identified individual patient produces a significant difference for that patient, as determined by the prescribing clinician.[2] FDA materials also describe compounding as a way to tailor a medication to an individual patient’s needs, such as changing the dose, strength, dosage form, or certain ingredients when clinically necessary.[3]

Personalized medicine should allow us to personalize the prescription.

Depending on the woman, customization may involve an individualized hormone strength, a more precise dose adjustment, a particular estrogen formulation, a selected estradiol and estriol ratio when appropriate, carefully titrated testosterone, a different delivery vehicle, or separate routes for different hormones.

Personalization does not mean placing every possible hormone into one preparation.

Sometimes the most individualized approach involves combining selected hormones.

Sometimes it means keeping them separate.

Sometimes estrogen needs adjustment while testosterone does not.

Sometimes progesterone requires its own dosing strategy.

Sometimes a woman receiving systemic therapy may still benefit from local vaginal treatment.

The purpose of compounding is not to prescribe more.

The purpose is to have the flexibility to prescribe more precisely.

Bioidentical Hormones and Individualized Care

Bioidentical hormones have the same molecular structure as hormones produced by the human body.

In my practice, I often use bioidentical hormone strategies when they are appropriate for the woman I am treating.

But the word bioidentical is only part of the conversation.

I am much more interested in questions such as:

Which hormone does she need?

What symptom or physiologic change are we addressing?

What dose makes sense?

What route makes sense?

Does she have a uterus?

What is happening with her sexual function?

What is happening with her vaginal tissues?

How is she sleeping?

What is happening metabolically?

What are her individual risk factors?

How is she responding to treatment?

Those are the questions that turn hormone prescribing into thoughtful menopause medicine.

Estrogen Is About Much More Than Hot Flashes

Most women think about estrogen primarily in relation to hot flashes and night sweats.

Estrogen affects much more than temperature regulation.

The vagina, vulva, urethra, and bladder are hormone responsive tissues.

When estrogen and androgen signaling decline during menopause, women can develop a group of changes now called genitourinary syndrome of menopause, or GSM.

The 2025 AUA, SUFU, and AUGS guideline recognizes GSM as a spectrum of genital and urinary symptoms associated with menopause and declining hormonal stimulation.[4]

Symptoms may include vaginal dryness, burning, irritation, reduced lubrication, tissue fragility, painful intercourse, urinary urgency, urinary frequency, discomfort with urination, and recurrent urinary symptoms.

Sexual sensation and sexual response may also change.

One of the important things women should understand is that GSM does not necessarily behave like hot flashes.

Hot flashes may eventually improve.

Genitourinary symptoms frequently persist and may require treatment.[4,5]

This is why I routinely ask women questions that may feel very personal.

Has sex become painful?

Has lubrication changed?

Has genital sensation changed?

Has orgasm changed?

Do you still experience desire?

Are you avoiding intimacy because you anticipate discomfort?

Are you experiencing urinary symptoms?

These are not side issues.

They are part of menopause health.

Progesterone Is Part of the Larger Picture

Progesterone is another important part of the hormonal orchestra.

For a woman with an intact uterus who receives systemic estrogen, appropriate progestogen exposure is generally needed to protect the endometrium.

Progesterone also interacts with the central nervous system, and individual women may notice differences in sleep and other symptoms depending on the formulation, dose, timing, and route.

Again, this is why menopause cannot be reduced to estrogen alone.

The hormonal environment needs to be considered as a whole.

Testosterone Matters in Women Too

Women produce testosterone.

Women have androgen receptors.

Androgen signaling plays an important role in female sexual physiology.

International consensus recommendations and subsequent clinical guidance support testosterone therapy for appropriately evaluated postmenopausal women with hypoactive sexual desire disorder.[6,7]

But when a woman tells me that her libido has disappeared, I do not automatically assume testosterone is the entire answer.

I want to understand what happened.

Is intercourse painful?

Has vaginal dryness developed?

Has genital sensation changed?

Is poor sleep affecting desire?

Could a medication be contributing?

Is thyroid dysfunction part of the picture?

Is metabolic health affecting energy and vascular function?

Is pelvic floor dysfunction making intimacy uncomfortable?

Does she truly have hypoactive sexual desire disorder?

Sexual desire is complex.

Testosterone can be an important part of the solution for the right woman, but it still belongs within the larger hormonal orchestra.

DHEA, Pregnenolone, and Hormonal Pathways

DHEA and pregnenolone provide another example of how interconnected hormonal physiology can be.

DHEA can be converted within peripheral tissues into downstream androgenic and estrogenic compounds.

Vaginal prasterone, which is DHEA, has evidence supporting its use for moderate to severe dyspareunia associated with menopausal vulvovaginal changes.[8]

Pregnenolone sits further upstream in steroidogenesis and serves as a precursor within several steroid hormone pathways.

This does not mean every woman should receive DHEA or pregnenolone.

Personalization is not about adding as many hormones as possible.

More hormones do not necessarily mean better hormone therapy.

The goal is to determine which elements are relevant to the individual woman.

Menopause Medicine Has Changed

Many women remain frightened of hormone therapy because of information they heard following the early Women’s Health Initiative reports more than two decades ago.

Our understanding of menopausal hormone therapy has become considerably more nuanced.

Today the conversation includes a woman’s age, time since menopause, symptoms, uterine status, formulation, route, dose, cardiovascular history, thrombotic risk, breast history, bone health, metabolic health, and individual goals.

The Menopause Society continues to identify hormone therapy as the most effective treatment for bothersome vasomotor symptoms and emphasizes individualized assessment of benefits and risks.[5]

In February 2026, the FDA approved labeling changes to six menopausal hormone therapy products. Statements related to cardiovascular disease, breast cancer, and probable dementia were removed from the boxed warnings for those products as the agency updated the benefit and risk information.[9]

That does not mean hormone therapy is appropriate for every woman.

It means women deserve a current and individualized discussion rather than a decision based solely on fear.

Sexual Health Is Part of Women’s Health

Sexual health is one of the areas of menopause care that I believe deserves much more attention.

Women are routinely asked about mammograms, blood pressure, cholesterol, and weight.

Far fewer are asked:

Does intercourse hurt?

Has your genital sensation changed?

Can you still become aroused?

Can you reach orgasm?

Has orgasm changed in intensity?

Has your desire changed?

Do you avoid intimacy because it has become uncomfortable?

These are medical questions.

Sexual function involves hormonal signaling, vascular health, neurologic function, genital tissue integrity, pelvic floor function, medications, pain, emotional well being, and relationship factors.

Menopause may affect several of those areas simultaneously.

For a woman who values intimacy, these changes can have a profound effect on quality of life.

I do not believe sexual health should be dismissed simply because a woman has reached menopause.

Where the O-Shot® Fits Into Menopause Care

This is where hormone therapy and regenerative sexual medicine can intersect.

The O-Shot® is an autologous platelet based regenerative procedure.

Autologous means that the biological material comes from the patient’s own blood.

A blood sample is collected and processed to concentrate platelets and platelet associated signaling factors. The resulting platelet preparation is then administered to selected areas of female genital tissue according to the treatment protocol.

Platelets release signaling molecules involved in normal tissue repair, vascular signaling, extracellular matrix activity, and cellular communication.

The interest in platelet based regenerative medicine for women’s sexual health comes from the possibility of influencing local tissue biology in areas that may be affected by menopause.

Why the O-Shot® May Be Particularly Relevant During Menopause

During menopause, declining hormonal stimulation can contribute to changes in vaginal and vulvar tissues.

The tissues may become thinner.

Hydration may decrease.

Elasticity can change.

Lubrication may decline.

The tissues may become more fragile.

Some women experience pain with intercourse.

Others notice reduced sensation.

Some find it more difficult to become aroused.

Some notice changes in orgasm.

These changes can arise from several mechanisms.

Hormonal changes are part of the picture.

Tissue quality is part of the picture.

Vascular function matters.

Neurologic function matters.

Pelvic floor function matters.

That is why I do not see BHRT and the O-Shot® as competing treatments.

They address different aspects of the problem.

BHRT addresses the hormonal environment. The O-Shot® addresses local regenerative tissue biology.

For an appropriately selected menopausal woman, these approaches may complement one another.

What Does the Research on Vaginal PRP Tell Us?

Research involving vaginal and vulvar platelet rich plasma has grown significantly.

It is important to distinguish the broader research on vaginal PRP from any single proprietary treatment protocol because studies vary in preparation methods, platelet concentration, injection sites, volume, and treatment schedule.

Still, the growing literature gives us useful information.

A prospective, double blinded randomized controlled study published in BMC Women’s Health in 2025 evaluated 60 postmenopausal women with vulvovaginal atrophy. Thirty women received intravaginal PRP and thirty received saline placebo. After four months, the PRP group demonstrated significantly greater improvement in total Female Sexual Function Index scores, with improvements in lubrication, satisfaction, and pain.[10]

Another 2025 controlled trial studied 90 postmenopausal women and compared three monthly sessions of intravaginal PRP with twelve weeks of vaginal estriol. Both groups experienced improvements in sexual function and vaginal health during the study period, suggesting that PRP may offer a meaningful tissue directed option for selected postmenopausal women.[11]

A separate randomized controlled trial published in Obstetrics & Gynecology in 2026 compared anterior vaginal wall PRP with saline placebo in 52 sexually active premenopausal women. Women receiving PRP had greater improvement in total sexual function scores, and approximately 69 percent reported improvement at both six weeks and six months. No serious adverse events were reported.[12]

Because that trial involved premenopausal women, it should not be interpreted as a menopause specific trial. It does, however, add controlled evidence to the literature examining vaginal PRP and female sexual function.

A systematic review published in the Journal of Sexual Medicine evaluated 18 studies involving 480 patients. Across the studies, PRP was associated with improvements in symptoms, sexual function, and vaginal health, although differences in preparation protocols and study design remain important limitations.[13]

The science is developing.

That is precisely why patient selection and clinical judgment matter.

What Changes Are Women Hoping to Improve?

Women seek consultation for the O-Shot® for different reasons.

Some notice decreased genital sensation.

Some experience changes in orgasm intensity.

Some have greater difficulty reaching orgasm.

Some describe reduced arousal.

Some have vaginal dryness or menopausal tissue changes.

Others experience discomfort with intimacy.

Published studies of vaginal PRP have reported improvements in areas such as lubrication, pain, sexual satisfaction, vaginal health, and overall sexual function in selected populations.[10,11,12,13]

Every woman responds differently.

There is no single procedure that can promise the same result for everyone.

The important question is whether the woman’s symptoms and underlying physiology make regenerative treatment a reasonable part of her care.

Hormones and Regenerative Medicine Can Address Different Parts of the Same Problem

Consider a postmenopausal woman who develops vaginal dryness.

Intercourse begins to hurt.

Because it hurts, her pelvic floor tightens protectively.

She begins anticipating pain.

Arousal becomes more difficult.

She becomes less sexually active.

Her sexual confidence declines.

Eventually she tells me:

“I lost my libido.”

But was loss of desire actually the original problem?

Perhaps not.

The decline in desire may have followed months or years of dryness, pain, altered tissue response, and avoidance.

Testosterone alone may not solve that.

An O-Shot® alone may not solve it either.

This is why understanding the sequence matters.

For one woman, personalized compounded BHRT may be central to treatment.

Another may need additional local vaginal hormone therapy.

Another may need pelvic floor treatment.

Another may have an appropriate indication for testosterone.

For another, regenerative treatment may add a valuable tissue directed component.

Some women may need more than one approach because those therapies are addressing different biological mechanisms.

The goal is not to do more treatment. The goal is to treat the right mechanisms.

The Pelvic Floor Matters Too

The pelvic floor is an essential part of female health, yet many women do not think about these muscles until something begins to change.

The pelvic floor helps support the bladder, urethra, vagina, rectum, and pelvic organs.

It plays an important role in urinary control.

It also participates in sexual function.

Pregnancy and childbirth can affect these muscles.

Aging can affect them.

Menopausal changes in the surrounding tissues may also influence how the entire pelvic region functions.

Some women begin leaking urine when they laugh, cough, sneeze, exercise, or lift.

Others develop urgency.

Some notice diminished pelvic muscle strength.

For some women, pelvic floor dysfunction also becomes part of the sexual health picture.

That is why pelvic floor function is an important part of our approach to menopausal intimate wellness.

Where Emsella Fits In

At Mirelle, one of the technologies we use to address pelvic floor muscle weakness is Emsella®.

Emsella uses high intensity focused electromagnetic energy to stimulate deep pelvic floor muscle contractions while the patient remains seated and fully clothed. Its intended use includes pelvic floor muscle strengthening for the treatment of urinary incontinence.[14]

The goal is to improve pelvic floor muscle recruitment, strength, and neuromuscular control.

This can be particularly helpful for women who have difficulty effectively engaging the pelvic floor muscles on their own.

Emsella as a Stand Alone Therapy

Not every woman needs hormones, regenerative treatment, and pelvic floor therapy simultaneously.

Sometimes the dominant problem is pelvic floor weakness.

A woman may feel very well hormonally but leak urine every time she exercises, laughs, coughs, or sneezes.

Another woman may primarily notice decreased pelvic floor strength following pregnancy, childbirth, or aging.

In these situations, Emsella may be considered as a stand alone treatment when the clinical assessment suggests that pelvic floor muscle weakness and urinary control are the primary concerns.

Clinical studies of high intensity focused electromagnetic therapy have reported improvement in stress and mixed urinary incontinence and quality of life measures in women.[15,16]

The important principle is the same one that guides the rest of menopause care.

Treat the dominant problem.

If the primary issue is muscular, then treating the muscle may be exactly what that woman needs.

Emsella as Part of Combination Therapy

Menopause frequently affects more than one system.

Imagine a woman who has declining estrogen and androgen stimulation.

Her vaginal tissues become dry and uncomfortable.

She begins having pain during intercourse.

At the same time, she has pelvic floor weakness from previous pregnancies, childbirth, or aging.

Now she is also leaking urine when she exercises.

Perhaps she worries about leakage during intimacy.

Her sexual confidence decreases.

She becomes less interested in sex because intimacy has become complicated rather than pleasurable.

In a woman like this, addressing only one mechanism may leave other important issues unresolved.

This is where a combination strategy can make sense.

Personalized BHRT may support the hormonal environment.

Local vaginal treatment can address hormonally responsive tissues when needed.

The O-Shot® may provide a regenerative stimulus directed toward selected genital tissues.

Emsella addresses something neither hormone therapy nor PRP directly replaces, which is pelvic floor muscle recruitment and strength.

These treatments are therefore not interchangeable.

They are aimed at different biological targets.

BHRT, the O-Shot®, and Emsella Address Three Different Areas

I often think about menopausal intimate health in three broad physiologic domains.

1. The Hormonal Environment

This is where personalized BHRT can become important.

We consider estrogen, progesterone, androgen physiology, symptoms, metabolism, medical history, and the larger endocrine environment.

2. The Genital Tissues

This is where local vaginal therapy and regenerative strategies such as the O-Shot® may become relevant.

We are thinking about tissue comfort, hydration, lubrication, vascular signaling, sensation, sexual response, and regenerative biology.

3. The Pelvic Floor Muscles

This is where Emsella may have an important role.

We are addressing muscle recruitment, strength, neuromuscular control, and urinary support.

These three domains influence one another, but they are not the same.

Hormone therapy does not directly retrain a weak pelvic floor.

Emsella does not replace hormonal support for estrogen responsive vaginal tissue.

The O-Shot® does not replace treatment of significant muscle dysfunction.

This is why a comprehensive evaluation matters.

Emsella, Menopause, and Sexual Function

Pelvic floor function and sexual function are connected.

A randomized study published in Obstetrics & Gynecology Science in 2024 evaluated 50 postmenopausal women with pelvic floor weakness and sexual dysfunction.

Women receiving high intensity focused electromagnetic therapy together with pelvic floor exercises had greater improvement in pelvic floor strength, endurance, sexual function, and menopause related quality of life than women performing pelvic floor exercises alone.[17]

This does not mean every sexual concern is a pelvic floor problem.

It means pelvic floor function deserves to be considered as one part of a much larger system.

For the right woman, improving muscle function may contribute not only to urinary control, but also to comfort, confidence, and sexual well being.

Sometimes One Treatment Is Enough

This is important.

A woman with isolated pelvic floor weakness may benefit from Emsella without needing an O-Shot®.

A woman with menopausal dryness and pain but excellent pelvic floor function may need hormonal and local tissue therapy without Emsella.

A woman whose primary concern is diminished sexual desire may need careful evaluation of hormonal, medication, psychological, relationship, tissue, and other contributors.

Another woman may present with vaginal dryness, diminished sexual response, urinary leakage, pelvic floor weakness, poor sleep, and declining libido.

Her treatment strategy may involve several systems.

The point is not to combine treatments simply because they are available.

The point is to combine treatments when the physiology gives us a reason to do so.

The Hormonal Environment and Tissue Health Are Connected

Regenerative medicine does not occur separately from the rest of the body.

The tissues we are treating exist within a biological environment.

Hormones influence epithelial health, vascular function, tissue hydration, and sexual physiology.

Metabolic health influences vascular function and inflammatory signaling.

Sleep influences endocrine function and recovery.

Thyroid dysfunction can affect energy, metabolism, and well being.

Pelvic floor dysfunction can perpetuate pain.

This is why I think about regenerative sexual medicine in the context of the entire woman.

Sometimes improving the hormonal or metabolic environment may be just as important as the local procedure.

Painful Intercourse Deserves a Careful Evaluation

Dyspareunia, or painful intercourse, is common during menopause, but it is not a single diagnosis.

Pain can come from GSM.

It can result from dryness or inadequate lubrication.

Pelvic floor muscles may be excessively tight.

Scar tissue may contribute.

A vulvar dermatologic condition may be present.

A woman may have a history of surgery, childbirth injury, or trauma.

There may be neurologic factors.

Sometimes several contributors exist together.

This is why I do not believe every woman with painful intercourse should simply be offered the same treatment.

First, we need to understand why it hurts.

Then we can decide whether treatment should involve systemic hormones, local vaginal therapy, pelvic floor care, regenerative medicine, or some combination.

Bringing It All Together

Imagine a woman who comes to Mirelle because she says she has lost interest in sex.

If we stop at that statement, we might assume she simply has low libido.

But when we listen more carefully, we discover that she developed vaginal dryness after menopause.

Intercourse began to hurt.

Because she expected pain, her pelvic floor began to guard.

At the same time, her pelvic floor had weakened and she began leaking urine during exercise.

She started worrying about urinary leakage during intimacy.

Sex became less spontaneous.

Arousal became more difficult.

She became less sexually active.

Her confidence declined.

Eventually, the way she described the entire experience was:

“I don’t want sex anymore.”

Her symptom is real.

But underneath that one symptom may be several very different biological problems.

Perhaps hormonal support needs to be adjusted.

Perhaps her vaginal tissues need direct treatment.

Perhaps the pelvic floor needs attention.

Perhaps Emsella can help strengthen and retrain weakened muscles.

Perhaps regenerative treatment with the O-Shot® is appropriate for her tissue and sexual concerns.

Perhaps testosterone is relevant.

Perhaps several of these interventions belong in the strategy.

Or perhaps only one does.

That is why the first step at Mirelle is not a machine, an injection, or a prescription.

The first step is understanding the woman.

Once we understand the hormonal environment, tissue health, pelvic floor function, sexual symptoms, metabolic health, medical history, and personal goals, we can begin creating the appropriate strategy.

That is what personalized care means to me.

The Mirelle Approach: Treat the Entire Orchestra

My 10- step menopause framework is straightforward:

1. Understand the Woman

Start with her symptoms, history, goals, sleep, metabolic health, sexual health, pelvic floor health, and quality of life.

2. Evaluate the Hormonal Environment

Consider estrogen, progesterone, androgen physiology, thyroid function, and other relevant systems together.

3. Personalize Hormone Therapy

When compounded BHRT allows us to more precisely meet the woman’s clinical needs, the prescription can be individualized accordingly.

4. Address the Genitourinary Tissues

Systemic treatment and local treatment are not always interchangeable.

Some women need additional treatment directed specifically to vaginal and vulvar tissues.

5. Ask About Sexual Function

Desire, arousal, lubrication, sensation, orgasm, comfort, and pain all deserve to be discussed.

6. Evaluate the Pelvic Floor

Muscle weakness, coordination, urinary leakage, urgency, pain, and guarding can all influence how a woman feels and functions.

7. Use Emsella When Muscle Function Is Part of the Problem

Emsella can be used as a focused pelvic floor treatment when muscle weakness or urinary control is the predominant concern.

It can also be integrated into a larger plan when hormonal, tissue, sexual, and pelvic floor changes overlap.

8. Consider Regenerative Sexual Medicine When Appropriate

For selected women, the O-Shot® may provide another therapeutic pathway directed toward local tissue biology.

9. Look at the Larger Metabolic Picture

Sleep, thyroid physiology, body composition, vascular health, insulin sensitivity, nutrition, and overall metabolic health affect how a woman feels.

10. Reassess

Precision medicine is a process.

We listen.

We evaluate.

We adjust.

We continue the conversation.

Menopause Should Not Mean Losing Yourself

Longevity means more to me than simply extending lifespan.

Healthspan is about preserving the ability to live well.

Can you move comfortably?

Can you think clearly?

Can you sleep?

Can you maintain strength and bone?

Can you remain metabolically healthy?

Do you have energy?

Do you feel comfortable in your body?

Do you still recognize yourself?

Can you laugh, exercise, or travel without worrying about urinary leakage?

And if sexual intimacy matters to you, can you continue to experience it comfortably and meaningfully?

A woman can have normal blood pressure and still wake drenched in sweat every night.

She can exercise regularly and still feel frustrated by changes in body composition.

She can be successful in every visible area of her life while privately wondering where her vitality went.

She can deeply love her partner and begin avoiding intimacy because sex hurts.

She can stop exercising the way she wants because she is afraid she will leak urine.

These concerns are not superficial.

They are part of health and quality of life.

Women Deserve a Better Menopause Conversation

I do not believe women should simply be told:

“This is aging. You have to live with it.”

I also do not believe in promising that one hormone, one supplement, one device, or one procedure will solve every menopausal symptom.

Female physiology is more complex than that.

A better conversation begins with better questions.

What changed?

Why did it change?

Which systems are involved?

What does this woman want to improve?

What can hormone therapy address?

What needs local treatment?

Is the pelvic floor involved?

Would Emsella address an important part of the problem?

Would regenerative medicine add something meaningful?

What other health factors need attention?

Sometimes the answer includes personalized compounded BHRT.

Sometimes it includes local vaginal treatment.

Sometimes testosterone is appropriate.

Sometimes metabolic optimization is essential.

Sometimes pelvic floor treatment with Emsella matters enormously.

Sometimes regenerative treatment with the O-Shot® becomes part of the strategy.

Often, several elements work together.

That is how I think about menopause care at Mirelle Institute for Longevity & Regenerative Medicine.

• Understand the woman.
• Understand the hormones.
• Understand the tissue.
• Understand the pelvic floor.
• Understand the metabolism.
• Understand the sexual physiology.
• Then create the strategy.

Because menopause is not a one hormone problem.

And women deserve care that recognizes the whole picture.

Ready for a Different Menopause Conversation?

If you are experiencing hot flashes, disrupted sleep, fatigue, changes in body composition, vaginal dryness, painful intimacy, urinary symptoms, loss of libido, reduced sensation, changes in orgasm, urinary leakage, or simply the persistent feeling that you are no longer yourself, those symptoms deserve to be heard.

At Mirelle Institute for Longevity & Regenerative Medicine in Manasquan, New Jersey, my goal is to understand what has changed and create an individualized plan around your physiology, symptoms, medical history, and goals.

That plan may include personalized compounded BHRT, hormone optimization, local vaginal therapy, metabolic medicine, Emsella pelvic floor therapy, sexual wellness treatment, or regenerative therapy such as the O-Shot® when appropriate.

You do not have to assume that every change you experience during menopause is simply something you must accept.

Sometimes the most important first step is having a more complete conversation.

If you are ready for an in-depth conversation, you can schedule your consultation here.